We further found that colorectal cancer patients with low expression of FAM198B in TAMs had a better prognosis than those with high FAM198B expression in TAMs, suggesting that FAM198B may serve as a potential biomarker for prognostic assessment. The gene discussed is GASK1B; the disease is colorectal cancer.